• LC-MS reveals differences between primary and metastatic pancreatic cancer cells
    Pancreatic cancer cells have been analysed using liquid chromatography-mass spectrometry

HPLC, UHPLC

LC-MS reveals differences between primary and metastatic pancreatic cancer cells

Sep 14 2010

Metastatic pancreatic cancer cells - which have spread from elsewhere in the body - significantly differ from those which develop in the organ itself, analysis with liquid chromatography and tandem mass spectrometry (LC-MS) reveals.

Scientists at the University of California, Los Angeles applied LC-MS to the analysis of membrane proteomes found in primary and metastatic pancreatic cancer cells.

They found 109 proteins that were present in both cell lines, indicating some similarities between the two.

However, in total they detected 221 proteins in metastatic AsPC-1 cells and 208 proteins in primary BxPC-3 cells.

With almost half of all the proteins identified appearing only in one cell type, the researchers conclude that metastatic and primary cells differ significantly.

As a result, they suggest targeting the differentially expressed proteins in the cell membranes with therapeutic or diagnostic interventions in the future.

The Journal of Biomedical Science is edited by Michael M C Lai of National Cheng Kung University and supported by the National Science Council of Taiwan.

Digital Edition

Chromatography Today - Buyers' Guide 2022

December 2021

In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

MC 2023

Feb 26 2023 Darmstadt, Germany

analytica China - NEW DATES

Mar 01 2023 Shanghai, China

China Lab 2023

Mar 09 2023 Guangzhou, China

PITTCON 2023

Mar 18 2023 Philadelphia, PA, USA

ACS National Meeting & Expo, Spring 2023

Mar 26 2023 Indianapolis, IN, USA

View all events